Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Older men who receive pneumococcal vaccine not less likely to have heart attack, stroke: JAMA

Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine, according to a study in the May 5 issue of JAMA.

5 May 2010

Cryo-EM images shed light on virus structure, function

UCLA researchers report in the April 30 edition of the journal Cell that they have imaged a virus structure at a resolution high enough to effectively "see" atoms, the first published instance of imaging biological complexes at such a resolution.

5 May 2010

Vical commences enrollment in Phase 1 trial of Vaxfectin DNA pandemic influenza vaccine

Vical Incorporated today announced the enrollment of the first subject in its Phase 1 trial of the company's Vaxfectin®-formulated plasmid DNA (pDNA) pandemic influenza vaccine. The trial will be conducted in collaboration with the U.S. Naval Medical Research Center (NMRC).

5 May 2010

Decreasing radiotherapy doses given to 'cold spots' can help reduce side-effects

Fine-tuning radiotherapy to take into account which parts of a patient's tumor are growing fastest could improve control of cancer while subjecting patients to lower doses of radiation, Dutch researchers reported today at the 2nd European Lung Cancer Conference.

5 May 2010

Meda AB's net sales for first-quarter 2010 decrease 14% to SEK 2,943M

After a strong Q4 in 2009, net sales decreased 14% in Q1 to SEK 2,943 million (3,437). Mainly currency effects but also increased competition for Astelin and Optivar reduced sales by more than SEK 400 million, compared with the same period last year.

5 May 2010

Azithromycin does not improve lung function in children with cystic fibrosis

Children and adolescents with cystic fibrosis who received the antibiotic azithromycin did not experience improved lung function, compared to patients who received placebo, according to a study in the May 5 issue of JAMA.

5 May 2010

Eight states to receive grants for local health programs

Pregnant women in eight states will receive prenatal services and education from the March of Dimes, thanks to a $313,000 grant from the WellPoint Foundation, Inc., a private, nonprofit organization wholly funded by WellPoint, Inc.

5 May 2010

Calgary doctors research how to minimize complications from Cryptococcus disease

Cryptococcus disease is a rare but serious infection resulting from inhaling a toxic fungus often found in fir trees. Approximately 250 people have been infected with the disease in British Columbia since its emergence in 1999. The disease can cause meningitis, pneumonia and in 10 per cent of cases it can lead to death.

5 May 2010

Results from STEALTH C-3 clinical trial of nitazoxanide presented at DDW 2010

Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented this afternoon as an oral communication at a late breaking forum of the American Gastroenterological Association Institute during Digestive Disease Week 2010 in New Orleans, Louisiana.

5 May 2010

New findings show seaweed extract inhibits H1N1 virus

In a breakthrough that offers new hope for the containment of influenza outbreaks, an Australian biotechnology company has isolated a natural extract from seaweed which has been shown to inhibit the H1N1 virus.

5 May 2010

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors, today reported financial results for the first quarter ended March 31, 2010.

5 May 2010

Widespread support for a full flu vaccine side effects enquiry

After nearly 250 children suffered from serious side effects of the seasonal flu shots including one death the Western Australian Government’s step to suspend further vaccinations and investigate the issue has received widespread support. The enquiry will look into the Health Department's handling of the flu vaccination program as well.

4 May 2010

Response Biomedical first-quarter total revenue down 43%

Response Biomedical Corporation today announced financial results for the first quarter ended March 31, 2010.

4 May 2010

CVS Caremark's net revenues increase $366M to $23.8 billion for first-quarter 2010

CVS Caremark Corporation, today announced revenues, operating profit, and net income for the three months ended March 31, 2010.

4 May 2010

Aethlon Medical plans to initiate patient recruitment for cancer immunotherapy study

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it plans to initiate patient recruitment for a cancer immunotherapy study by year end. The pilot study seeks to demonstrate an improved immune function in cancer patients as a result of the Aethlon Hemopurifier removing tumor-secreted exosomes from the circulatory system.

4 May 2010

Tenet Healthcare reports adjusted EBITDA of $298 million for first-quarter 2010

Tenet Healthcare Corporation today reported adjusted EBITDA of $298 million for the quarter ended March 31, 2010, an increase of $20 million, or 7.2 percent, as compared to $278 million for the first quarter of 2009. Net income attributable to common shareholders for the first quarter of 2010 was $88 million, or $0.17 per diluted share, compared to $44 million, or $0.09 per diluted share, excluding a gain of $134 million, or $0.28 per diluted share, in the first quarter of 2009 related to the early extinguishment of debt.

4 May 2010

Pilot pneumonia-prevention program reduces postoperative pneumonia in hospital surgical ward: Research

The results of new research results published in the April issue of the Journal of the American College of Surgeons show that a pilot pneumonia-prevention program significantly reduced postoperative pneumonia in a hospital surgical ward.

4 May 2010

MicroStockProfit.com releases investment report on Vical

MicroStockProfit.com announces an investment report featuring Vical Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

4 May 2010

Immune system responds aggressively when looking at sick people

Just seeing someone who looks sick is enough to make your immune system work harder, according to a new study in which volunteers looked at pictures of sick people. This may help fight off pathogens, says Mark Schaller from the University of British Columbia who conducted the research. "It seems like it's probably good for the immune system to be responding especially aggressively at times when it looks like you are likely to be coming into contact with something that might make you sick."

4 May 2010

NIH awards $3.4M grant for preclinical development of novel Staphylococcus aureus vaccine

GlycoVaxyn AG, a leader in the development of innovative bioconjugate vaccines, and Professor Jean Lee, principal investigator at the Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, announced today that they have received a USD 3.4 million NIH grant to finance preclinical development of a novel Staphylococcus aureus vaccine. S. aureus is a major cause of hospital-based infections.

4 May 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Older men who receive pneumococcal vaccine not less likely to have heart attack, stroke: JAMA

Cryo-EM images shed light on virus structure, function

Vical commences enrollment in Phase 1 trial of Vaxfectin DNA pandemic influenza vaccine

Decreasing radiotherapy doses given to 'cold spots' can help reduce side-effects

Meda AB's net sales for first-quarter 2010 decrease 14% to SEK 2,943M

Azithromycin does not improve lung function in children with cystic fibrosis

Eight states to receive grants for local health programs

Calgary doctors research how to minimize complications from Cryptococcus disease

Results from STEALTH C-3 clinical trial of nitazoxanide presented at DDW 2010

New findings show seaweed extract inhibits H1N1 virus

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Widespread support for a full flu vaccine side effects enquiry

Response Biomedical first-quarter total revenue down 43%

CVS Caremark's net revenues increase $366M to $23.8 billion for first-quarter 2010

Aethlon Medical plans to initiate patient recruitment for cancer immunotherapy study

Tenet Healthcare reports adjusted EBITDA of $298 million for first-quarter 2010

Pilot pneumonia-prevention program reduces postoperative pneumonia in hospital surgical ward: Research

MicroStockProfit.com releases investment report on Vical

Immune system responds aggressively when looking at sick people

NIH awards $3.4M grant for preclinical development of novel Staphylococcus aureus vaccine

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in